Trends in Age and Disease Severity in Children Hospitalized With RSV Infection Before and During the COVID-19 Pandemic

Cristina Garcia-Maurino; Helena Brenes-Chacón; Katia C Halabi; Pablo J Sánchez; Octavio Ramilo; Asuncion Mejias

doi:10.1001/jamapediatrics.2023.5431

Trends in Age and Disease Severity in Children Hospitalized With RSV Infection Before and During the COVID-19 Pandemic

JAMA Pediatr. 2024 Feb 1;178(2):195-197. doi: 10.1001/jamapediatrics.2023.5431.

Authors

Cristina Garcia-Maurino¹, Helena Brenes-Chacón², Katia C Halabi³, Pablo J Sánchez⁴, Octavio Ramilo⁵, Asuncion Mejias⁵

Affiliations

¹ Institute for Global Health, University College London, London, United Kingdom.
² Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus.
³ Division of Infectious Diseases, Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio.
⁴ Division of Neonatology, Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio.
⁵ Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee.

No abstract available

Plain language summary

This cohort study evaluates respiratory syncytial virus (RSV)–related hospitalizations and disease severity from 2012 to 2023 in children younger than 5 years.

MeSH terms

COVID-19*
Child
Hospitalization
Humans
Infant
Pandemics
Patient Acuity
Respiratory Syncytial Virus Infections* / epidemiology
Respiratory Tract Infections* / epidemiology

Plain language summary

MeSH terms

Grants and funding